–
Cue Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.7
FY22:
−53.2
FY23:
−52.1
FY24:
−41.5
FY25:
−26.6
(positive)
millions USD
FY21:
−43.7
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY22
millions USD
FY21:
−43.7
FY22:
−53.0
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−44.2
FY22:
−53.0
FY23:
−50.7
FY24:
−40.7
FY25:
−26.6
All amounts in millions USD